Trial intelligence / Profile preview

Effects of propofol versus sevoflurane and anesthesia method on immune function during hepatectomy

ChiCTR-IPR-15006841Phase 4Recruiting

Sponsor
Eastern Hepatobiliary Surgery Hospital
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol and sevoflurane in liver cancer (3 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Number of immune cells. Started Aug 2015; status: recruiting.

02

Drugs

propofolsevoflurane
03

Conditions

liver cancer

Beyond the preview

Go deeper on ChiCTR-IPR-15006841.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15006841.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call